| First Author | Neves J | Year | 2020 |
| Journal | Exp Gerontol | Volume | 134 |
| Pages | 110893 | PubMed ID | 32119994 |
| Mgi Jnum | J:299760 | Mgi Id | MGI:6490038 |
| Doi | 10.1016/j.exger.2020.110893 | Citation | Neves J, et al. (2020) MANF delivery improves retinal homeostasis and cell replacement therapies in ageing mice. Exp Gerontol 134:110893 |
| abstractText | Ageing is a major risk factor for vision loss, and inflammation is an important contributor to retinal disease in the elderly. Regenerative medicine based on cell replacement strategies has emerged in recent years as a promising approach to restore vision. However, how the ageing process affects retinal homeostasis and inflammation in the retina and how this may impose a limitation to the success of such interventions remains unknown. Here we report that, in mice and humans, retinal ageing is associated with a reduction in MANF protein levels, specifically in the choroid, where increased densities of activated macrophages can be detected. We further show that the retina of old wild type mice, in the absence of any other genetic alteration, has limited homeostatic capacity after damage imposed by light exposure and reduced engraftment efficiency of exogenously supplied photoreceptors. Finally, we show that supplementation of MANF recombinant protein can improve retinal homeostasis and repair capacity in both settings, correlating with reduced numbers of activated macrophages in the old retina. Our work identifies age-related alterations in retinal homeostasis, independent of genetic alterations, leading to age-related retinal inflammation and damage susceptibility. We suggest that MANF therapy is a potential intervention to maintain retinal homeostasis in the elderly and improve the success of retinal regenerative therapies applied to aged individuals. |
